Bottom line
PAWZ vs AWSHX: the short answer
PAWZ (ProShares Pet Care ETF) and AWSHX (Washington Mutual Investors Fund) are both etfs.
But AWSHX is far broader, holding 200 positions to 38 for PAWZ, so beyond the top names it adds exposure PAWZ doesn't have.
PAWZ is cheaper at 0.5% vs 0.55% — a difference of $5.00 a year per $10,000 invested.
Over five years, AWSHX returned +12.6% a year vs −4.7% for PAWZ.
AWSHX has a front-end sales load of up to 5.75%; the other does not.
Updated Nov 19, 2026
PAWZ vs AWSHX side by side
| PAWZ | AWSHX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | ProShares | American Funds (Capital Group) |
| Category | Large Blend | Large Blend |
| Expense ratio | 0.5% | 0.55% |
| Annual cost per $10k | $50 | $55 |
| 10-yr cost on $10k (prospectus) | $628 | $1,225 |
| Max front load | None | 5.75% |
| 12b-1 fee | — | 0.24% |
| 1-yr return | +0.9% | +10.4% |
| 5-yr return (annualized) | −4.7% | +12.6% |
| 10-yr return (annualized) | — | +12.5% |
| Best quarter | +26.2% | +16.5% |
| Worst quarter | −20.7% | −21.5% |
| Net assets (fund) | $32.5M | $218.0B |
| Number of holdings | 38 | 200 |
| Portfolio turnover | 41% | 32% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
PAWZ and AWSHX share none of their top holdings.
PAWZ top 10
- IDEXX Laboratories, Inc. — 10.15%
- Chewy, Inc. — 9.90%
- Freshpet, Inc. — 9.81%
- Zoetis, Inc. — 9.46%
- Virbac SACA — 7.37%
- CVS Group plc — 4.99%
- Merck & Co., Inc. — 4.84%
- Pets at Home Group plc — 4.71%
- Nestle SA — 4.64%
- Oil-Dri Corp. of America — 4.50%
AWSHX top 10
- Broadcom Inc — 6.54%
- Microsoft Corp — 4.83%
- Philip Morris International Inc — 3.70%
- Capital Group Central Cash Fund — 3.31%
- Apple Inc — 3.30%
- Eli Lilly And Co — 1.82%
- Bank Of America Corp — 1.81%
- Welltower Inc — 1.77%
- Marsh & Mclennan Companies Inc — 1.76%
- Alphabet Inc — 1.74%
FAQ
What is the difference between PAWZ and AWSHX?
Which is cheaper, PAWZ or AWSHX?
Should I own both PAWZ and AWSHX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.